HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MT1-MMP expression in first-trimester placental tissue is upregulated in type 1 diabetes as a result of elevated insulin and tumor necrosis factor-alpha levels.

AbstractOBJECTIVE:
In pregestational diabetes, the placenta at term of gestation is characterized by various structural and functional changes. Whether similar alterations occur in the first trimester has remained elusive. Placental development requires proper trophoblast invasion and tissue remodeling, processes involving matrix metalloproteinases (MMPs) of which the membrane-anchored members (MT-MMPs) such as MT1-MMPs are key players. Here, we hypothesize a dysregulation of placental MT1-MMP in the first trimester of type 1 diabetic pregnancies induced by the diabetic environment.
RESEARCH DESIGN AND METHODS:
MT1-MMP protein was measured in first-trimester placentas of healthy (n = 13) and type 1 diabetic (n = 13) women. To identify potential regulators, first-trimester trophoblasts were cultured under hyperglycemia and various insulin, IGF-I, IGF-II, and tumor necrosis factor-alpha (TNF-alpha) concentrations in presence or absence of signaling pathway inhibitors.
RESULTS:
MT1-MMP was strongly expressed in first-trimester trophoblasts. In type 1 diabetes, placental pro-MT1-MMP was upregulated, whereas active MT1-MMP expression was only increased in late first trimester. In isolated primary trophoblasts, insulin, IGF-I, IGF-II, and TNF-alpha upregulated MT1-MMP expression, whereas glucose had no effect. The insulin effect was dependent on phosphatidylinositol 3-kinase, the IGF-I effect on mitogen-activated protein kinase, and the IGF-II effect on both.
CONCLUSIONS:
This is the first study reporting alterations in the first-trimester placenta in type 1 diabetes. The upregulated MT1-MMP expression in type 1 diabetes may be the result of higher maternal insulin and TNF-alpha levels. We speculate that the elevated MT1-MMP will affect placental development and may thus contribute to long-term structural alterations in the placenta in pregestational diabetes.
AuthorsUrsula Hiden, Elisabeth Glitzner, Marina Ivanisevic, Josip Djelmis, Christian Wadsack, Uwe Lang, Gernot Desoye
JournalDiabetes (Diabetes) Vol. 57 Issue 1 Pg. 150-7 (Jan 2008) ISSN: 1939-327X [Electronic] United States
PMID17928399 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Insulin
  • Tumor Necrosis Factor-alpha
  • MMP14 protein, human
  • Matrix Metalloproteinase 14
Topics
  • Abortion, Spontaneous (enzymology, genetics)
  • Cell Culture Techniques
  • Diabetes Mellitus, Type 1 (complications, enzymology, genetics)
  • Female
  • Gene Expression Regulation, Enzymologic
  • Humans
  • Insulin (blood)
  • Matrix Metalloproteinase 14 (genetics)
  • Placenta (enzymology)
  • Pregnancy
  • Pregnancy Complications (enzymology, genetics)
  • Pregnancy Trimester, First
  • Reference Values
  • Trophoblasts (cytology, enzymology)
  • Tumor Necrosis Factor-alpha (blood)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: